Hepcidin predicts response to IV iron therapy in patients admitted to the intensive care unit: a nested cohort study.

Edward LittonStuart BakerWendy ErberShannon FarmerJanet FerrierCraig FrenchJoel GummerDavid HawkinsAlisa HigginsAxel HofmannBart De KeulenaerJulie McMorrowJohn K OlynykToby RichardsSimon TowlerRobert TrengoveSteve Webbnull nullnull null

Published in: Journal of intensive care (2018)

Australian New Zealand Clinical Trials Registry: ANZCTRN12612001249 Registered 26/11/2012.

Keyphrases

clinical trial
iron deficiency
phase ii
stem cells
case control
mesenchymal stem cells
bone marrow
phase iii
cell therapy